Broker talks up AstraZeneca's lung cancer drug prospects
Jefferies upgraded the health giant to a 'buy' recommendation
Company
Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
79 stories · page 4 of 4
Healthy oil rise keeps markets afloat, helps energy stocks
Investors cautious on Monday following a burst of optimism
US markets ease back from record levels
A strong non-farm payrolls number eased some concerns in the market over the health of the US economy.
US shares mark record highs after NFP upside surprise
Wall Street shares marked fresh record highs on Friday after US non-farm payrolls beat consensus forecasts - by a huge margin
Records broken by S&P 500, S&P 400 and S&P 600 indexes after forecast-beating NFP
US stocks stormed higher at midsession on Friday, with the S&P 500 and mid-cap S&P 400 both chalking a fresh record high after non-farm payrolls in July hugely outstripped expectations
Bristol Myers slumps as immunotherapy drug fails lung cancer trial
The news immediately boosted shares in Merck (NYSE:MRK), which has a rival immunotherapy treatment, Keytruda.
Archive
Brokers: Jefferies warming to Baker-Hughes's strategy shift
Companies covered: Baker-Hughes, Bristol-Myers Squibb, Western Digital, GrubHub, Oshkosh, Harley Davidson, NetSuite, Pinnacle Foodsx
Bristol Myers/ Janssen target lung cancer with I-O combo
The Phase II clinical trial will evaluate the tolerability and clinical activity of the combination of two agents
Bristol-Myers Squibb to get keys to Padlock
Bristol-Myers Squibb Company is to snap up Padlock Therapeutics
Stocks find forward gear at last
The oil price (WTI) had its best day in seven years
Archive
Wall Street rallies on spate of deal-making
A flurry of M&A provided many of Monday’s highlights.
Wall Street dealmakers in rude health, stocks rally
A flurry of M&A provided many of Monday’s highlights
Wall Street to start Monday positively, traders eye M&A
Visa, Dyax, Bristol-Myers Squibb, MedAssets, Coty and TreeHouse Foods are all involved in new deals
Bristol-Myers to take over Crioxyl Pharma in $2.1bn deal
Bristol-Myers aims to to gain access to Cardioxyl's CXL-1427, a heart failure treatment.
Cancer drug firms to cash in on $9bn immunotherapy market
Trials have shown that immunotherapy may revolutionise cancer treatment
Wall Street rises as investors take positive read on mixed data; OM surges
Wall Street rose today, the first day of trade for June, as investors took a positive read on mixed second quarter economic reports. The S&P 500 (INDEXSP:.INX) rose 0.4 percent to 2,115 at 3:31 p.m. in New York. The 30-company Dow Jones